nodes	percent_of_prediction	percent_of_DWPC	metapath
Ciprofloxacin—TOP2A—Teniposide—lymphatic system cancer	0.263	0.339	CbGbCtD
Ciprofloxacin—TOP2A—Mitoxantrone—lymphatic system cancer	0.184	0.237	CbGbCtD
Ciprofloxacin—CYP1A2—Carmustine—lymphatic system cancer	0.0598	0.0772	CbGbCtD
Ciprofloxacin—CYP3A5—Teniposide—lymphatic system cancer	0.054	0.0697	CbGbCtD
Ciprofloxacin—CYP3A7—Vincristine—lymphatic system cancer	0.0346	0.0447	CbGbCtD
Ciprofloxacin—CYP3A7-CYP3A51P—Vincristine—lymphatic system cancer	0.0346	0.0447	CbGbCtD
Ciprofloxacin—CYP3A5—Vincristine—lymphatic system cancer	0.026	0.0335	CbGbCtD
Ciprofloxacin—ABCB1—Mitoxantrone—lymphatic system cancer	0.0246	0.0317	CbGbCtD
Ciprofloxacin—CYP3A4—Cytarabine—lymphatic system cancer	0.0214	0.0276	CbGbCtD
Ciprofloxacin—CYP3A4—Teniposide—lymphatic system cancer	0.021	0.0272	CbGbCtD
Ciprofloxacin—ABCB1—Vincristine—lymphatic system cancer	0.0169	0.0218	CbGbCtD
Ciprofloxacin—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0147	0.019	CbGbCtD
Ciprofloxacin—ABCB1—Methotrexate—lymphatic system cancer	0.0102	0.0132	CbGbCtD
Ciprofloxacin—CYP3A4—Vincristine—lymphatic system cancer	0.0101	0.0131	CbGbCtD
Ciprofloxacin—TOP2A—Etoposide—Teniposide—lymphatic system cancer	0.00111	0.195	CbGdCrCtD
Ciprofloxacin—TOP2A—Podofilox—Teniposide—lymphatic system cancer	0.000846	0.149	CbGdCrCtD
Ciprofloxacin—TOP2A—Vindesine—Vincristine—lymphatic system cancer	0.000798	0.14	CbGdCrCtD
Ciprofloxacin—TOP2A—Vinorelbine—Vincristine—lymphatic system cancer	0.000504	0.0884	CbGdCrCtD
Ciprofloxacin—TOP2A—Cladribine—Fludarabine—lymphatic system cancer	0.000381	0.0669	CbGdCrCtD
Ciprofloxacin—TOP2A—Clofarabine—Fludarabine—lymphatic system cancer	0.000352	0.0619	CbGdCrCtD
Ciprofloxacin—TOP2A—Vinblastine—Vincristine—lymphatic system cancer	0.000346	0.0608	CbGdCrCtD
Ciprofloxacin—TOP2A—Clofarabine—Cytarabine—lymphatic system cancer	0.000333	0.0584	CbGdCrCtD
Ciprofloxacin—TOP2A—Gemcitabine—Cytarabine—lymphatic system cancer	0.000308	0.0541	CbGdCrCtD
Ciprofloxacin—TOP2A—Cytarabine—Fludarabine—lymphatic system cancer	0.0003	0.0526	CbGdCrCtD
Ciprofloxacin—TOP2A—Azacitidine—Fludarabine—lymphatic system cancer	0.000215	0.0377	CbGdCrCtD
Ciprofloxacin—TOP2A—Azacitidine—Cytarabine—lymphatic system cancer	0.000203	0.0356	CbGdCrCtD
Ciprofloxacin—Agitation—Carmustine—lymphatic system cancer	0.000182	0.000827	CcSEcCtD
Ciprofloxacin—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000181	0.000824	CcSEcCtD
Ciprofloxacin—Asthenia—Fludarabine—lymphatic system cancer	0.000181	0.000824	CcSEcCtD
Ciprofloxacin—Rash—Teniposide—lymphatic system cancer	0.000181	0.000823	CcSEcCtD
Ciprofloxacin—Dermatitis—Teniposide—lymphatic system cancer	0.000181	0.000823	CcSEcCtD
Ciprofloxacin—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.00018	0.000819	CcSEcCtD
Ciprofloxacin—Headache—Teniposide—lymphatic system cancer	0.00018	0.000818	CcSEcCtD
Ciprofloxacin—Pruritus—Fludarabine—lymphatic system cancer	0.000179	0.000812	CcSEcCtD
Ciprofloxacin—Lymphadenopathy—Methotrexate—lymphatic system cancer	0.000178	0.000811	CcSEcCtD
Ciprofloxacin—Back pain—Mitoxantrone—lymphatic system cancer	0.000178	0.000809	CcSEcCtD
Ciprofloxacin—Leukopenia—Carmustine—lymphatic system cancer	0.000177	0.000806	CcSEcCtD
Ciprofloxacin—Anorexia—Bleomycin—lymphatic system cancer	0.000176	0.000802	CcSEcCtD
Ciprofloxacin—Thrombophlebitis—Methotrexate—lymphatic system cancer	0.000176	0.0008	CcSEcCtD
Ciprofloxacin—Anaemia—Vincristine—lymphatic system cancer	0.000175	0.000794	CcSEcCtD
Ciprofloxacin—Agitation—Vincristine—lymphatic system cancer	0.000174	0.00079	CcSEcCtD
Ciprofloxacin—Vision blurred—Mitoxantrone—lymphatic system cancer	0.000173	0.000789	CcSEcCtD
Ciprofloxacin—Photosensitivity—Methotrexate—lymphatic system cancer	0.000173	0.000788	CcSEcCtD
Ciprofloxacin—Polyuria—Methotrexate—lymphatic system cancer	0.000173	0.000788	CcSEcCtD
Ciprofloxacin—Hypotension—Bleomycin—lymphatic system cancer	0.000173	0.000786	CcSEcCtD
Ciprofloxacin—Diarrhoea—Fludarabine—lymphatic system cancer	0.000173	0.000785	CcSEcCtD
Ciprofloxacin—Convulsion—Carmustine—lymphatic system cancer	0.000172	0.00078	CcSEcCtD
Ciprofloxacin—Hypertension—Carmustine—lymphatic system cancer	0.000171	0.000777	CcSEcCtD
Ciprofloxacin—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000171	0.000776	CcSEcCtD
Ciprofloxacin—Nausea—Teniposide—lymphatic system cancer	0.000171	0.000776	CcSEcCtD
Ciprofloxacin—Anaemia—Mitoxantrone—lymphatic system cancer	0.00017	0.000773	CcSEcCtD
Ciprofloxacin—Vertigo—Vincristine—lymphatic system cancer	0.00017	0.000772	CcSEcCtD
Ciprofloxacin—Hepatic failure—Methotrexate—lymphatic system cancer	0.000169	0.00077	CcSEcCtD
Ciprofloxacin—Leukopenia—Vincristine—lymphatic system cancer	0.000169	0.000769	CcSEcCtD
Ciprofloxacin—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000169	0.000767	CcSEcCtD
Ciprofloxacin—Chest pain—Carmustine—lymphatic system cancer	0.000169	0.000766	CcSEcCtD
Ciprofloxacin—Myalgia—Carmustine—lymphatic system cancer	0.000169	0.000766	CcSEcCtD
Ciprofloxacin—Anxiety—Carmustine—lymphatic system cancer	0.000168	0.000764	CcSEcCtD
Ciprofloxacin—Paraesthesia—Bleomycin—lymphatic system cancer	0.000166	0.000756	CcSEcCtD
Ciprofloxacin—Malaise—Mitoxantrone—lymphatic system cancer	0.000166	0.000755	CcSEcCtD
Ciprofloxacin—Dyspnoea—Bleomycin—lymphatic system cancer	0.000165	0.00075	CcSEcCtD
Ciprofloxacin—Renal failure acute—Methotrexate—lymphatic system cancer	0.000165	0.00075	CcSEcCtD
Ciprofloxacin—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000165	0.000749	CcSEcCtD
Ciprofloxacin—Convulsion—Vincristine—lymphatic system cancer	0.000164	0.000744	CcSEcCtD
Ciprofloxacin—Hypertension—Vincristine—lymphatic system cancer	0.000163	0.000742	CcSEcCtD
Ciprofloxacin—Confusional state—Carmustine—lymphatic system cancer	0.000163	0.000741	CcSEcCtD
Ciprofloxacin—Oedema—Carmustine—lymphatic system cancer	0.000162	0.000735	CcSEcCtD
Ciprofloxacin—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.000161	0.000734	CcSEcCtD
Ciprofloxacin—Decreased appetite—Bleomycin—lymphatic system cancer	0.000161	0.000732	CcSEcCtD
Ciprofloxacin—Myalgia—Vincristine—lymphatic system cancer	0.000161	0.000732	CcSEcCtD
Ciprofloxacin—Visual disturbance—Methotrexate—lymphatic system cancer	0.000161	0.000731	CcSEcCtD
Ciprofloxacin—Cough—Mitoxantrone—lymphatic system cancer	0.000161	0.00073	CcSEcCtD
Ciprofloxacin—Vomiting—Fludarabine—lymphatic system cancer	0.000161	0.00073	CcSEcCtD
Ciprofloxacin—Convulsion—Mitoxantrone—lymphatic system cancer	0.000159	0.000725	CcSEcCtD
Ciprofloxacin—Rash—Fludarabine—lymphatic system cancer	0.000159	0.000724	CcSEcCtD
Ciprofloxacin—Dermatitis—Fludarabine—lymphatic system cancer	0.000159	0.000723	CcSEcCtD
Ciprofloxacin—Hypertension—Mitoxantrone—lymphatic system cancer	0.000159	0.000722	CcSEcCtD
Ciprofloxacin—Pain—Bleomycin—lymphatic system cancer	0.000158	0.00072	CcSEcCtD
Ciprofloxacin—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000158	0.000719	CcSEcCtD
Ciprofloxacin—Headache—Fludarabine—lymphatic system cancer	0.000158	0.000719	CcSEcCtD
Ciprofloxacin—Tachycardia—Carmustine—lymphatic system cancer	0.000158	0.000717	CcSEcCtD
Ciprofloxacin—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	0.000157	0.000715	CcSEcCtD
Ciprofloxacin—Chest pain—Mitoxantrone—lymphatic system cancer	0.000157	0.000712	CcSEcCtD
Ciprofloxacin—Myalgia—Mitoxantrone—lymphatic system cancer	0.000157	0.000712	CcSEcCtD
Ciprofloxacin—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000157	0.000712	CcSEcCtD
Ciprofloxacin—Anxiety—Mitoxantrone—lymphatic system cancer	0.000156	0.00071	CcSEcCtD
Ciprofloxacin—Lethargy—Methotrexate—lymphatic system cancer	0.000155	0.000706	CcSEcCtD
Ciprofloxacin—Discomfort—Mitoxantrone—lymphatic system cancer	0.000155	0.000704	CcSEcCtD
Ciprofloxacin—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000154	0.000701	CcSEcCtD
Ciprofloxacin—Oedema—Vincristine—lymphatic system cancer	0.000154	0.000701	CcSEcCtD
Ciprofloxacin—Anorexia—Carmustine—lymphatic system cancer	0.000154	0.0007	CcSEcCtD
Ciprofloxacin—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000153	0.000694	CcSEcCtD
Ciprofloxacin—Confusional state—Mitoxantrone—lymphatic system cancer	0.000151	0.000689	CcSEcCtD
Ciprofloxacin—Nervous system disorder—Vincristine—lymphatic system cancer	0.000151	0.000688	CcSEcCtD
Ciprofloxacin—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000151	0.000687	CcSEcCtD
Ciprofloxacin—Hypotension—Carmustine—lymphatic system cancer	0.000151	0.000686	CcSEcCtD
Ciprofloxacin—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.00015	0.000683	CcSEcCtD
Ciprofloxacin—Oedema—Mitoxantrone—lymphatic system cancer	0.00015	0.000683	CcSEcCtD
Ciprofloxacin—Nausea—Fludarabine—lymphatic system cancer	0.00015	0.000682	CcSEcCtD
Ciprofloxacin—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000149	0.000678	CcSEcCtD
Ciprofloxacin—Shock—Mitoxantrone—lymphatic system cancer	0.000148	0.000672	CcSEcCtD
Ciprofloxacin—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000147	0.000669	CcSEcCtD
Ciprofloxacin—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000147	0.000669	CcSEcCtD
Ciprofloxacin—Urticaria—Bleomycin—lymphatic system cancer	0.000147	0.000669	CcSEcCtD
Ciprofloxacin—Anorexia—Vincristine—lymphatic system cancer	0.000147	0.000668	CcSEcCtD
Ciprofloxacin—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000147	0.000667	CcSEcCtD
Ciprofloxacin—Body temperature increased—Bleomycin—lymphatic system cancer	0.000146	0.000665	CcSEcCtD
Ciprofloxacin—Insomnia—Carmustine—lymphatic system cancer	0.000146	0.000664	CcSEcCtD
Ciprofloxacin—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000146	0.000663	CcSEcCtD
Ciprofloxacin—Irritability—Methotrexate—lymphatic system cancer	0.000145	0.000661	CcSEcCtD
Ciprofloxacin—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000145	0.00066	CcSEcCtD
Ciprofloxacin—Paraesthesia—Carmustine—lymphatic system cancer	0.000145	0.00066	CcSEcCtD
Ciprofloxacin—Hypotension—Vincristine—lymphatic system cancer	0.000144	0.000655	CcSEcCtD
Ciprofloxacin—Dyspnoea—Carmustine—lymphatic system cancer	0.000144	0.000655	CcSEcCtD
Ciprofloxacin—Somnolence—Carmustine—lymphatic system cancer	0.000144	0.000653	CcSEcCtD
Ciprofloxacin—Anorexia—Mitoxantrone—lymphatic system cancer	0.000143	0.000651	CcSEcCtD
Ciprofloxacin—Ataxia—Methotrexate—lymphatic system cancer	0.000143	0.000651	CcSEcCtD
Ciprofloxacin—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.000141	0.000639	CcSEcCtD
Ciprofloxacin—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000141	0.000639	CcSEcCtD
Ciprofloxacin—Decreased appetite—Carmustine—lymphatic system cancer	0.00014	0.000639	CcSEcCtD
Ciprofloxacin—Hypotension—Mitoxantrone—lymphatic system cancer	0.00014	0.000638	CcSEcCtD
Ciprofloxacin—Insomnia—Vincristine—lymphatic system cancer	0.00014	0.000634	CcSEcCtD
Ciprofloxacin—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00014	0.000634	CcSEcCtD
Ciprofloxacin—Paraesthesia—Vincristine—lymphatic system cancer	0.000139	0.00063	CcSEcCtD
Ciprofloxacin—Pain—Carmustine—lymphatic system cancer	0.000138	0.000628	CcSEcCtD
Ciprofloxacin—Constipation—Carmustine—lymphatic system cancer	0.000138	0.000628	CcSEcCtD
Ciprofloxacin—Breast disorder—Methotrexate—lymphatic system cancer	0.000138	0.000626	CcSEcCtD
Ciprofloxacin—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.000137	0.000623	CcSEcCtD
Ciprofloxacin—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000137	0.000622	CcSEcCtD
Ciprofloxacin—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000136	0.00062	CcSEcCtD
Ciprofloxacin—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000135	0.000613	CcSEcCtD
Ciprofloxacin—Decreased appetite—Vincristine—lymphatic system cancer	0.000134	0.00061	CcSEcCtD
Ciprofloxacin—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000134	0.000609	CcSEcCtD
Ciprofloxacin—Somnolence—Mitoxantrone—lymphatic system cancer	0.000134	0.000607	CcSEcCtD
Ciprofloxacin—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000133	0.000605	CcSEcCtD
Ciprofloxacin—Feeling abnormal—Carmustine—lymphatic system cancer	0.000133	0.000605	CcSEcCtD
Ciprofloxacin—Fatigue—Vincristine—lymphatic system cancer	0.000133	0.000605	CcSEcCtD
Ciprofloxacin—Asthenia—Bleomycin—lymphatic system cancer	0.000133	0.000604	CcSEcCtD
Ciprofloxacin—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000132	0.000601	CcSEcCtD
Ciprofloxacin—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000132	0.000601	CcSEcCtD
Ciprofloxacin—Constipation—Vincristine—lymphatic system cancer	0.000132	0.0006	CcSEcCtD
Ciprofloxacin—Pain—Vincristine—lymphatic system cancer	0.000132	0.0006	CcSEcCtD
Ciprofloxacin—Asthma—Methotrexate—lymphatic system cancer	0.000132	0.000598	CcSEcCtD
Ciprofloxacin—Pruritus—Bleomycin—lymphatic system cancer	0.000131	0.000595	CcSEcCtD
Ciprofloxacin—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000131	0.000594	CcSEcCtD
Ciprofloxacin—Eosinophilia—Methotrexate—lymphatic system cancer	0.00013	0.000592	CcSEcCtD
Ciprofloxacin—Fatigue—Mitoxantrone—lymphatic system cancer	0.00013	0.000589	CcSEcCtD
Ciprofloxacin—Pancreatitis—Methotrexate—lymphatic system cancer	0.000129	0.000587	CcSEcCtD
Ciprofloxacin—Constipation—Mitoxantrone—lymphatic system cancer	0.000128	0.000584	CcSEcCtD
Ciprofloxacin—Pain—Mitoxantrone—lymphatic system cancer	0.000128	0.000584	CcSEcCtD
Ciprofloxacin—Abdominal pain—Carmustine—lymphatic system cancer	0.000128	0.000581	CcSEcCtD
Ciprofloxacin—Body temperature increased—Carmustine—lymphatic system cancer	0.000128	0.000581	CcSEcCtD
Ciprofloxacin—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.000126	0.000574	CcSEcCtD
Ciprofloxacin—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000126	0.000573	CcSEcCtD
Ciprofloxacin—Pancytopenia—Methotrexate—lymphatic system cancer	0.000125	0.000568	CcSEcCtD
Ciprofloxacin—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000124	0.000563	CcSEcCtD
Ciprofloxacin—Dysuria—Methotrexate—lymphatic system cancer	0.000123	0.00056	CcSEcCtD
Ciprofloxacin—Neutropenia—Methotrexate—lymphatic system cancer	0.000123	0.00056	CcSEcCtD
Ciprofloxacin—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000123	0.000558	CcSEcCtD
Ciprofloxacin—Abdominal pain—Vincristine—lymphatic system cancer	0.000122	0.000554	CcSEcCtD
Ciprofloxacin—Body temperature increased—Vincristine—lymphatic system cancer	0.000122	0.000554	CcSEcCtD
Ciprofloxacin—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.00012	0.000546	CcSEcCtD
Ciprofloxacin—Urticaria—Mitoxantrone—lymphatic system cancer	0.000119	0.000543	CcSEcCtD
Ciprofloxacin—Hypersensitivity—Carmustine—lymphatic system cancer	0.000119	0.000541	CcSEcCtD
Ciprofloxacin—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000119	0.00054	CcSEcCtD
Ciprofloxacin—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000119	0.00054	CcSEcCtD
Ciprofloxacin—Pneumonia—Methotrexate—lymphatic system cancer	0.000118	0.000537	CcSEcCtD
Ciprofloxacin—Vomiting—Bleomycin—lymphatic system cancer	0.000118	0.000535	CcSEcCtD
Ciprofloxacin—Infestation—Methotrexate—lymphatic system cancer	0.000117	0.000534	CcSEcCtD
Ciprofloxacin—Infestation NOS—Methotrexate—lymphatic system cancer	0.000117	0.000534	CcSEcCtD
Ciprofloxacin—Drowsiness—Methotrexate—lymphatic system cancer	0.000117	0.000534	CcSEcCtD
Ciprofloxacin—Depression—Methotrexate—lymphatic system cancer	0.000117	0.000532	CcSEcCtD
Ciprofloxacin—Rash—Bleomycin—lymphatic system cancer	0.000117	0.000531	CcSEcCtD
Ciprofloxacin—Dermatitis—Bleomycin—lymphatic system cancer	0.000117	0.00053	CcSEcCtD
Ciprofloxacin—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000116	0.000529	CcSEcCtD
Ciprofloxacin—Asthenia—Carmustine—lymphatic system cancer	0.000116	0.000527	CcSEcCtD
Ciprofloxacin—Renal failure—Methotrexate—lymphatic system cancer	0.000115	0.000524	CcSEcCtD
Ciprofloxacin—Stomatitis—Methotrexate—lymphatic system cancer	0.000114	0.00052	CcSEcCtD
Ciprofloxacin—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000114	0.000519	CcSEcCtD
Ciprofloxacin—Hypersensitivity—Vincristine—lymphatic system cancer	0.000114	0.000517	CcSEcCtD
Ciprofloxacin—Sweating—Methotrexate—lymphatic system cancer	0.000113	0.000511	CcSEcCtD
Ciprofloxacin—Haematuria—Methotrexate—lymphatic system cancer	0.000112	0.000509	CcSEcCtD
Ciprofloxacin—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.000111	0.000505	CcSEcCtD
Ciprofloxacin—Epistaxis—Methotrexate—lymphatic system cancer	0.000111	0.000503	CcSEcCtD
Ciprofloxacin—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000111	0.000503	CcSEcCtD
Ciprofloxacin—Asthenia—Vincristine—lymphatic system cancer	0.000111	0.000503	CcSEcCtD
Ciprofloxacin—Diarrhoea—Carmustine—lymphatic system cancer	0.000111	0.000503	CcSEcCtD
Ciprofloxacin—Nausea—Bleomycin—lymphatic system cancer	0.00011	0.0005	CcSEcCtD
Ciprofloxacin—Agranulocytosis—Methotrexate—lymphatic system cancer	0.00011	0.000498	CcSEcCtD
Ciprofloxacin—Asthenia—Mitoxantrone—lymphatic system cancer	0.000108	0.00049	CcSEcCtD
Ciprofloxacin—Dizziness—Carmustine—lymphatic system cancer	0.000107	0.000486	CcSEcCtD
Ciprofloxacin—Haemoglobin—Methotrexate—lymphatic system cancer	0.000106	0.000481	CcSEcCtD
Ciprofloxacin—Diarrhoea—Vincristine—lymphatic system cancer	0.000106	0.00048	CcSEcCtD
Ciprofloxacin—Haemorrhage—Methotrexate—lymphatic system cancer	0.000105	0.000479	CcSEcCtD
Ciprofloxacin—Hepatitis—Methotrexate—lymphatic system cancer	0.000105	0.000479	CcSEcCtD
Ciprofloxacin—Pharyngitis—Methotrexate—lymphatic system cancer	0.000105	0.000475	CcSEcCtD
Ciprofloxacin—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.000104	0.000473	CcSEcCtD
Ciprofloxacin—Urethral disorder—Methotrexate—lymphatic system cancer	0.000103	0.000469	CcSEcCtD
Ciprofloxacin—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000103	0.000467	CcSEcCtD
Ciprofloxacin—Vomiting—Carmustine—lymphatic system cancer	0.000103	0.000467	CcSEcCtD
Ciprofloxacin—Dizziness—Vincristine—lymphatic system cancer	0.000102	0.000464	CcSEcCtD
Ciprofloxacin—Rash—Carmustine—lymphatic system cancer	0.000102	0.000463	CcSEcCtD
Ciprofloxacin—Dermatitis—Carmustine—lymphatic system cancer	0.000102	0.000463	CcSEcCtD
Ciprofloxacin—Visual impairment—Methotrexate—lymphatic system cancer	0.000102	0.000462	CcSEcCtD
Ciprofloxacin—Headache—Carmustine—lymphatic system cancer	0.000101	0.00046	CcSEcCtD
Ciprofloxacin—Erythema multiforme—Methotrexate—lymphatic system cancer	9.96e-05	0.000453	CcSEcCtD
Ciprofloxacin—Eye disorder—Methotrexate—lymphatic system cancer	9.85e-05	0.000448	CcSEcCtD
Ciprofloxacin—Tinnitus—Methotrexate—lymphatic system cancer	9.82e-05	0.000447	CcSEcCtD
Ciprofloxacin—Vomiting—Vincristine—lymphatic system cancer	9.81e-05	0.000446	CcSEcCtD
Ciprofloxacin—Cardiac disorder—Methotrexate—lymphatic system cancer	9.78e-05	0.000444	CcSEcCtD
Ciprofloxacin—Rash—Vincristine—lymphatic system cancer	9.73e-05	0.000442	CcSEcCtD
Ciprofloxacin—Dermatitis—Vincristine—lymphatic system cancer	9.72e-05	0.000442	CcSEcCtD
Ciprofloxacin—Headache—Vincristine—lymphatic system cancer	9.66e-05	0.000439	CcSEcCtD
Ciprofloxacin—Nausea—Carmustine—lymphatic system cancer	9.6e-05	0.000436	CcSEcCtD
Ciprofloxacin—Angiopathy—Methotrexate—lymphatic system cancer	9.56e-05	0.000435	CcSEcCtD
Ciprofloxacin—Vomiting—Mitoxantrone—lymphatic system cancer	9.55e-05	0.000434	CcSEcCtD
Ciprofloxacin—Immune system disorder—Methotrexate—lymphatic system cancer	9.52e-05	0.000433	CcSEcCtD
Ciprofloxacin—Mediastinal disorder—Methotrexate—lymphatic system cancer	9.49e-05	0.000432	CcSEcCtD
Ciprofloxacin—Rash—Mitoxantrone—lymphatic system cancer	9.47e-05	0.000431	CcSEcCtD
Ciprofloxacin—Dermatitis—Mitoxantrone—lymphatic system cancer	9.46e-05	0.00043	CcSEcCtD
Ciprofloxacin—Chills—Methotrexate—lymphatic system cancer	9.45e-05	0.00043	CcSEcCtD
Ciprofloxacin—Headache—Mitoxantrone—lymphatic system cancer	9.41e-05	0.000428	CcSEcCtD
Ciprofloxacin—Alopecia—Methotrexate—lymphatic system cancer	9.31e-05	0.000423	CcSEcCtD
Ciprofloxacin—Mental disorder—Methotrexate—lymphatic system cancer	9.23e-05	0.00042	CcSEcCtD
Ciprofloxacin—Erythema—Methotrexate—lymphatic system cancer	9.17e-05	0.000417	CcSEcCtD
Ciprofloxacin—Malnutrition—Methotrexate—lymphatic system cancer	9.17e-05	0.000417	CcSEcCtD
Ciprofloxacin—Nausea—Vincristine—lymphatic system cancer	9.16e-05	0.000417	CcSEcCtD
Ciprofloxacin—Dysgeusia—Methotrexate—lymphatic system cancer	8.98e-05	0.000408	CcSEcCtD
Ciprofloxacin—Nausea—Mitoxantrone—lymphatic system cancer	8.92e-05	0.000406	CcSEcCtD
Ciprofloxacin—Back pain—Methotrexate—lymphatic system cancer	8.87e-05	0.000403	CcSEcCtD
Ciprofloxacin—Vision blurred—Methotrexate—lymphatic system cancer	8.64e-05	0.000393	CcSEcCtD
Ciprofloxacin—Ill-defined disorder—Methotrexate—lymphatic system cancer	8.51e-05	0.000387	CcSEcCtD
Ciprofloxacin—Anaemia—Methotrexate—lymphatic system cancer	8.48e-05	0.000385	CcSEcCtD
Ciprofloxacin—Malaise—Methotrexate—lymphatic system cancer	8.27e-05	0.000376	CcSEcCtD
Ciprofloxacin—Vertigo—Methotrexate—lymphatic system cancer	8.24e-05	0.000375	CcSEcCtD
Ciprofloxacin—Leukopenia—Methotrexate—lymphatic system cancer	8.21e-05	0.000373	CcSEcCtD
Ciprofloxacin—Cough—Methotrexate—lymphatic system cancer	8e-05	0.000364	CcSEcCtD
Ciprofloxacin—Convulsion—Methotrexate—lymphatic system cancer	7.95e-05	0.000361	CcSEcCtD
Ciprofloxacin—Arthralgia—Methotrexate—lymphatic system cancer	7.81e-05	0.000355	CcSEcCtD
Ciprofloxacin—Myalgia—Methotrexate—lymphatic system cancer	7.81e-05	0.000355	CcSEcCtD
Ciprofloxacin—Chest pain—Methotrexate—lymphatic system cancer	7.81e-05	0.000355	CcSEcCtD
Ciprofloxacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	7.75e-05	0.000353	CcSEcCtD
Ciprofloxacin—Discomfort—Methotrexate—lymphatic system cancer	7.71e-05	0.000351	CcSEcCtD
Ciprofloxacin—Confusional state—Methotrexate—lymphatic system cancer	7.55e-05	0.000343	CcSEcCtD
Ciprofloxacin—Anaphylactic shock—Methotrexate—lymphatic system cancer	7.48e-05	0.00034	CcSEcCtD
Ciprofloxacin—Nervous system disorder—Methotrexate—lymphatic system cancer	7.34e-05	0.000334	CcSEcCtD
Ciprofloxacin—Thrombocytopenia—Methotrexate—lymphatic system cancer	7.33e-05	0.000333	CcSEcCtD
Ciprofloxacin—Skin disorder—Methotrexate—lymphatic system cancer	7.27e-05	0.000331	CcSEcCtD
Ciprofloxacin—Hyperhidrosis—Methotrexate—lymphatic system cancer	7.24e-05	0.000329	CcSEcCtD
Ciprofloxacin—Anorexia—Methotrexate—lymphatic system cancer	7.13e-05	0.000324	CcSEcCtD
Ciprofloxacin—Hypotension—Methotrexate—lymphatic system cancer	6.99e-05	0.000318	CcSEcCtD
Ciprofloxacin—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	6.82e-05	0.00031	CcSEcCtD
Ciprofloxacin—Insomnia—Methotrexate—lymphatic system cancer	6.77e-05	0.000308	CcSEcCtD
Ciprofloxacin—Paraesthesia—Methotrexate—lymphatic system cancer	6.72e-05	0.000306	CcSEcCtD
Ciprofloxacin—Dyspnoea—Methotrexate—lymphatic system cancer	6.67e-05	0.000303	CcSEcCtD
Ciprofloxacin—Somnolence—Methotrexate—lymphatic system cancer	6.65e-05	0.000303	CcSEcCtD
Ciprofloxacin—Dyspepsia—Methotrexate—lymphatic system cancer	6.59e-05	0.0003	CcSEcCtD
Ciprofloxacin—Decreased appetite—Methotrexate—lymphatic system cancer	6.51e-05	0.000296	CcSEcCtD
Ciprofloxacin—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	6.46e-05	0.000294	CcSEcCtD
Ciprofloxacin—Fatigue—Methotrexate—lymphatic system cancer	6.45e-05	0.000293	CcSEcCtD
Ciprofloxacin—Pain—Methotrexate—lymphatic system cancer	6.4e-05	0.000291	CcSEcCtD
Ciprofloxacin—Feeling abnormal—Methotrexate—lymphatic system cancer	6.17e-05	0.00028	CcSEcCtD
Ciprofloxacin—Gastrointestinal pain—Methotrexate—lymphatic system cancer	6.12e-05	0.000278	CcSEcCtD
Ciprofloxacin—Urticaria—Methotrexate—lymphatic system cancer	5.95e-05	0.00027	CcSEcCtD
Ciprofloxacin—Body temperature increased—Methotrexate—lymphatic system cancer	5.92e-05	0.000269	CcSEcCtD
Ciprofloxacin—Abdominal pain—Methotrexate—lymphatic system cancer	5.92e-05	0.000269	CcSEcCtD
Ciprofloxacin—Hypersensitivity—Methotrexate—lymphatic system cancer	5.51e-05	0.000251	CcSEcCtD
Ciprofloxacin—Asthenia—Methotrexate—lymphatic system cancer	5.37e-05	0.000244	CcSEcCtD
Ciprofloxacin—Pruritus—Methotrexate—lymphatic system cancer	5.3e-05	0.000241	CcSEcCtD
Ciprofloxacin—Diarrhoea—Methotrexate—lymphatic system cancer	5.12e-05	0.000233	CcSEcCtD
Ciprofloxacin—Dizziness—Methotrexate—lymphatic system cancer	4.95e-05	0.000225	CcSEcCtD
Ciprofloxacin—Vomiting—Methotrexate—lymphatic system cancer	4.76e-05	0.000216	CcSEcCtD
Ciprofloxacin—Rash—Methotrexate—lymphatic system cancer	4.72e-05	0.000215	CcSEcCtD
Ciprofloxacin—Dermatitis—Methotrexate—lymphatic system cancer	4.71e-05	0.000214	CcSEcCtD
Ciprofloxacin—Headache—Methotrexate—lymphatic system cancer	4.69e-05	0.000213	CcSEcCtD
Ciprofloxacin—Nausea—Methotrexate—lymphatic system cancer	4.45e-05	0.000202	CcSEcCtD
